US$ 20.70
fda warning bpc 157 safety not approved bpc-157 unapproved new drug The FDA has issued clear signals on BPC-157: it is for human use in any form due to potential significant risks. This critical Gray market peptides blur drug
Description
Every single batch of our peptides, including BPC-157, undergoes rigorous third-party testing to confirm its identity, purity, and quality

Gastroenterol 131 , 17681774 (2006)

Joint & Bone Health Support In-vitro and animal studies show BPC-157 promotes osteogenic differentiation and accelerates bone fracture healing
In the three human studies completed, the safety profile has been promising
